StreetAlpha
13F holdings · Q3 2026

Boxer Capital Management

San Diego, CA · files as Boxer Capital Management, LLC
Know the moment Boxer Capital Management filesYou follow Boxer Capital Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 2018299

Boxer Capital Management reported 47 stocks worth $1.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are TNGX (22.8%), KOD (12.2%) and RVMD (8.9%). Compared with Q2 2026, the fund opened new positions in ACHV, CCCC and TRAX, added to KYMR, REPL and SRZN, trimmed TNGX, ABVX and PGEN and sold out of VIR, PCVX and CRVS.

Latest filing: what Boxer Capital Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
12 new9 added13 trimmed28 sold outBought about $133M · sold about $263M
New 12
See all 12 →
Added 9
See all 9 →
Trimmed 13
See all 13 →
Sold out 28
See all 28 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$1.2B−13.3% vs last quarter
Stocks held4712 new · 28 sold out
Top 5 weight53.9%fairly concentrated
Turnover34%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
TNGX
Tango Therapeutics Inc
$263M22.8%10.5M−350K (−3%)8 of 8
2
KOD
Kodiak Sciences Inc
$140M12.2%1.5MNo change8 of 8
3
RVMD
Revolution Medicines Inc
$103M8.9%500KNo change8 of 8
4
KYMR
Kymera Therapeutics Inc
$58.6M5.1%525K+95K (+22%)8 of 8
5
REPL
Replimune Group Inc
$56.6M4.9%4.3M+295K (+7%)8 of 8
6
ABVX
Abivax SA
$47M4.1%475K−130K (−21%)5 of 8
7
SRZN
Surrozen Inc
$43.8M3.8%1.4M+255K (+23%)4 of 8
8
CORT
Corcept Therapeutics Inc
$38.7M3.4%336KNo change3 of 8
9
PGEN
Precigen Inc
$37M3.2%4.3M−830K (−16%)5 of 8
10
QURE
Uniqure NV
$34.4M3.0%1.4M−80K (−5%)8 of 8
🔒 37 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
VIR
Vir Biotechnology Inc
$19M1.9M
PCVX
Vaxcyte Inc
$18.9M325K
CRVS
Corvus Pharmaceuticals Inc
$16.4M1.1M
PTCT
Ptc Therapeutics Inc
$16.3M200K
PRAX
Praxis Precision Medicines I
$15.6M46K

🔒 Free account: see all 28.

Reported value

last 8 quarters
$1.2BQ4 '24
$332MQ1 '25
$199MQ2 '25
$314MQ3 '25
$457MQ4 '25
$762MQ1 '26
$1.3BQ2 '26
$1.2BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Boxer Capital Management 13F FAQ

What does Boxer Capital Management own?

Boxer Capital Management reported 47 stocks worth $1.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are TNGX (22.8%), KOD (12.2%) and RVMD (8.9%). The table above lists every position in the filing (the top 10 without an account).

What did Boxer Capital Management buy and sell in Q3 2026?

Compared with Q2 2026: 12 new positions, 9 added to, 13 trimmed and 28 sold out. New positions include ACHV, CCCC and TRAX. It sold all of VIR, PCVX and CRVS.

When will Boxer Capital Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Boxer Capital Management's portfolio worth?

The Q3 2026 filing reports $1.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.